Holen Sie sich die Stockscreener-App
26.01
3.31%
-0.89
Vorhandelsmarkt:
26.01
Schlusskurs vom Vortag:
$26.90
Offen:
$24.5
24-Stunden-Volumen:
1.95M
Relative Volume:
1.57
Marktkapitalisierung:
$1.98B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-64.16M
KGV:
-20.48
EPS:
-1.2702
Netto-Cashflow:
$-69.06M
1W Leistung:
+4.25%
1M Leistung:
+1.80%
6M Leistung:
-13.90%
1J Leistung:
-25.32%
1-Tages-Spanne:
$24.50
$26.77
1-Wochen-Bereich:
$24.50
$29.00
52-Wochen-Spanne:
$14.80
$40.47
Cg Oncology Inc Stock (CGON) Company Profile
Firmenname
Cg Oncology Inc
Sektor
Branche
Telefon
(949) 419-6203
Adresse
400 SPECTRUM CENTER DRIVE, IRVINE
Vergleichen Sie CGON mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CGON
Cg Oncology Inc
|
26.01 | 1.90B | 0 | -64.16M | -69.06M | -1.2702 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Cg Oncology Inc Stock (CGON) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-10 | Fortgesetzt | Goldman | Buy |
| 2025-05-02 | Eingeleitet | JP Morgan | Overweight |
| 2025-04-16 | Eingeleitet | Scotiabank | Sector Perform |
| 2025-01-07 | Eingeleitet | TD Cowen | Buy |
| 2024-10-24 | Eingeleitet | UBS | Buy |
| 2024-09-23 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-08-28 | Eingeleitet | ROTH MKM | Buy |
| 2024-06-28 | Eingeleitet | BofA Securities | Buy |
| 2024-02-20 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-02-20 | Eingeleitet | Goldman | Neutral |
| 2024-02-20 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-02-14 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Cg Oncology Inc Aktie (CGON) Neueste Nachrichten
CG Oncology Inc. Stock Analysis and ForecastTremendous gains - jammulinksnews.com
Is CG Oncology Inc. a good long term investmentExplosive returns - jammulinksnews.com
What drives CG Oncology Inc. stock priceTriple-digit return opportunities - jammulinksnews.com
Why CG Oncology Inc. stock attracts strong analyst attentionSteady Income Ideas - Newser
Why Did CG Oncology Plunge 10.78%? Insider Selling Sparks Concern - AInvest
What analysts say about CG Oncology Inc. stockConsistently high returns - PrintWeekIndia
Teacher Retirement System of Texas Cuts Position in CG Oncology, Inc. (NASDAQ:CGON) - Defense World
CG Oncology, Inc. (NASDAQ:CGON) Receives Consensus Rating of “Buy” from Brokerages - Defense World
Royal Bank Of Canada Issues Pessimistic Forecast for CG Oncology (NASDAQ:CGON) Stock Price - Defense World
September 19th Options Now Available For CG Oncology (CGON) - Nasdaq
Beyond The Numbers: 7 Analysts Discuss CG Oncology Stock - Benzinga
CG Oncology stock price target lowered to $53 at RBC Capital - Investing.com Canada
How CG Oncology Inc. stock performs during market volatilityFree Stock Selection - Newser
What makes CG Oncology Inc. stock price move sharplyFree Stock Movement Tracking - Newser
Morgan Stanley Lifts PT on CG Oncology (CGON) to $56, Keeps an Overweight Rating - MSN
CG Oncology Appoints Interim CFO After Resignation - The Globe and Mail
The Goldman Sachs Group Upgrades CG Oncology (NASDAQ:CGON) to “Strong-Buy” - Defense World
Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs - Finansavisen
CG Oncology's Strategic Pivot: How the Creto Pipeline is Redefining Value in Oncology Drug Development - AInvest
CG Oncology (NASDAQ:CGON) Upgraded to “Hold” at Wall Street Zen - Defense World
CG Oncology: Looking Undervalued Heading Toward FDA Submission (Upgrade) (NASDAQ:CGON) - Seeking Alpha
Cancer Rates Are Surging in Young Adults -- Here's Where the Smart Money Is Going - KamloopsBCNow
Cancer Rates Are Surging in Young Adults — Here’s Where the Smart Money Is Going - Cantech Letter
CG Oncology (NASDAQ:CGON) Price Target Raised to $56.00 at Morgan Stanley - Defense World
Rhumbline Advisers Buys 5,673 Shares of CG Oncology, Inc. (NASDAQ:CGON) - Defense World
CG Oncology (NASDAQ:CGON) Trading 4.7% Higher After Analyst Upgrade - Defense World
CGON: Morgan Stanley Raises Price Target for CG Oncology | CGON Stock News - GuruFocus
CG Oncology price target raised to $56 from $52 at Morgan Stanley - TipRanks
August 15th Options Now Available For CG Oncology (CGON) - Nasdaq
Non-Muscle Invasive Bladder Cancer Market Set to Grow Substantially Through 2034, DelveInsight Projects | CG Oncology, Pfizer, UroGen Pharma, Janssen Research & Development, LLC, Protara Therapeutics - The Globe and Mail
Cantor Fitzgerald Predicts CG Oncology FY2026 Earnings - Defense World
California State Teachers Retirement System Buys 20,763 Shares of CG Oncology, Inc. (NASDAQ:CGON) - Defense World
Squarepoint Ops LLC Makes New Investment in CG Oncology, Inc. (NASDAQ:CGON) - Defense World
CG Oncology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference - Bluefield Daily Telegraph
CG Oncology Brings Breakthrough Bladder Cancer Treatment to Goldman Sachs Healthcare Conference - Stock Titan
Ameriprise Financial Inc. Grows Stock Holdings in CG Oncology, Inc. (NASDAQ:CGON) - Defense World
Promising Market Position and Investment Opportunity: CG Oncology’s Creto in NMIBC Treatment - TipRanks
CG Oncology, Inc. (NASDAQ:CGON) Position Reduced by Nuveen Asset Management LLC - Defense World
BNP Paribas Financial Markets Lowers Stake in CG Oncology, Inc. (NASDAQ:CGON) - Defense World
CG Oncology, Inc. (NASDAQ:CGON) Receives Consensus Recommendation of “Buy” from Analysts - Defense World
Finanzdaten der Cg Oncology Inc-Aktie (CGON)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):